Radiotherapy, Radiopharmaceuticals & Nuclear Medicine Market by Type; By Production Method; By Technology; By Application; By Geography (North America, Asia-Pacific, Europe, South America, and RoW), Industry Trends, Estimation & Forecast, 2018 – 2026

pa_user-types

Check Today's Best Price

$3500 Buy Now
The Global Radiotherapy, Radiopharmaceuticals & Nuclear Medicine market is estimated at over $XX billion in 2018, with a projected CAGR of XX.X% during the forecast period.
  • Market Overview

    The Global Radiotherapy, Radiopharmaceuticals & Nuclear Medicine market is estimated at over $XX billion in 2018, with a projected CAGR of XX.X% during the forecast period. Radiotherapy means the use of radiation, usually x-rays, to treat cancer cells. Radiotherapy from inside the body is called internal radiotherapy. Or external radiotherapy is from outside of the body. Radiotherapy is always carefully organized by a team of experts. Radiotherapy treatment is continuing to become even more precise.

    Market Dynamics

    Increasing geriatric population, growing prevalence of cancer, surging healthcare spending in emerging economies, and growing focus on early diagnosis and treatment are the major factors driving the growth of the global radiotherapy, radiopharmaceuticals & nuclear medicine market. In addition, an increasing amount of nuclear imaging equipment, high efficiency of radiotherapy, and the launch of new radiopharmaceuticals and widening applications are also expected to fuel the market growth in the forecasted period. However, regulatory issues, lack of trained professionals, and expensive equipment may hamper the market from growing. Moreover, advancements in technologies, government funding, and personalized treatment are the aspects that are likely to present significant growth prospects for the radiotherapy, radiopharmaceuticals & nuclear medicine market share in the coming years.

    Market Segmentation

    The global radiotherapy, radiopharmaceuticals & nuclear medicine market is segmented based on the type, production method, technology, application, and geography. The type segment includes radiotherapy, external beam radiation therapy, internal radiation therapy, systemic radiotherapy, radiopharmaceuticals, diagnostics, and therapeutics. By the production method segment, the categorization is given as particle accelerators (cyclotrons), working of particle accelerators, nuclear reactors, radionuclide generators, and production of radioisotopes through radionuclides. By technology segment, the segmentation comprises of external radiotherapy market by technology, internal radiotherapy by technology, and systemic radiotherapy by technology. In addition, external beam radiation therapy, internal radiation therapy, and systemic radiation therapy are the classification of the application segment. Furthermore, geographical coverage has been offered for each of the major regions including North America, Asia-Pacific, Europe, Row, and South America.

    Scope of the Global Radiotherapy, Radiopharmaceuticals & Nuclear Medicine Market

    By Type

    • Radiotherapy
    • External Beam Radiation Therapy
    • Internal Radiation Therapy
    • Systemic Radiotherapy
    • Radiopharmaceuticals
    • Diagnostics
    • Therapeutics

    By Production Method

    • Particle Accelerators (Cyclotrons)
    • Working Of Particle Accelerators
    • Nuclear Reactors
    • Radionuclide Generators
    • Production Of Radioisotopes Through Radionuclides

    By Technology

    • External Radiotherapy
      • Particle Therapy/Proton Beam Therapy
      • Stereotactic Radiosurgery (SRS) and Fractioned Stereotactic Radiation Therapy
      • Image-Guided Radiation Therapy (IGRT)
      • Intensity-Modulated Radiation Therapy (IMRT)
      • Tomotherapy
      • Three-Dimensional Conformal Radiation Therapy (3D-CRT)
      • Volumetric Modulated Arc Therapy (VMAT)
    • Internal Radiotherapy
      • Pulse-Dose-Rate (PDR) Brachytherapy
      • Low-Dose-Rate Brachytherapy
      • High-Dose-Rate (HDR) Brachytherapy
    • Systemic Radiotherapy
      • Comparison between Alpha and Beta Emitters

    By Application

    • External Beam Radiation Therapy
      • Treatment Planning for External Beam Radiation
      • Dosing and Treatment with External Beam Radiation
      • Electron-Emitting High-Energy Linear Accelerators
    • Internal Radiation Therapy
    • Systemic Radiation Therapy

    By Geography

    • North America
      • The U.S.
      • Canada
      • Mexico
    • Europe
      • UK
      • France
      • Germany
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • Korea
      • Rest of APAC
    • South America
      • Brazil
      • Rest of South America
    • Rest of the World
      • Middle East
      • Africa
    keyboard_arrow_up
  • TABLE OF CONTENTS

    Chapter 1 Introduction
    1.1 Executive Summary
    1.2 Market Definition
    1.3 Market Scope

    Chapter 2 Research Methodology
    2.1 Primary Research
    2.2 Research Methodology
    2.3 Assumptions & Exclusions
    2.4 Secondary Data Sources

    Chapter 3 Market Overview
    3.1 Report Segmentation & Scope
    3.2 Key Market Trends
    3.2.1 Drivers
    3.2.2 Restraints
    3.2.3 Opportunities
    3.3 Porter’s Five Forces Analysis
    3.4 Market Share Analysis

    Chapter 4 Global Radiotherapy, Radiopharmaceuticals and Nuclear Medicine Market by Type: Market Size and Forecast, 2018 – 2026
    4.1 Introduction
    4.1.1 Market Size and Forecast
    4.2 Radiotherapy
    4.2.1 Market Size and Forecast
    4.3 External Beam Radiation Therapy
    4.3.1 Market Size and Forecast
    4.4 Internal Radiation Therapy
    4.4.1 Market Size and Forecast
    4.5 Systematic Radiotherapy
    4.5.1 Market Size and Forecast
    4.6 Radiopharmaceuticals
    4.6.1 Market Size and Forecast
    4.7 Diagnostics
    4.7.1 Market Size and Forecast
    4.8 Therapeutics
    4.8.1 Market Size and Forecast

    Chapter 5 Global Radiotherapy, Radiopharmaceuticals and Nuclear Medicine Market by Production Type: Market Size and Forecast, 2018 – 2026
    5.1 Introduction
    5.1.1 Market Size and Forecast
    5.2 Particle Accelerators (Cyclotrons)
    5.2.1 Market Size and Forecast
    5.3 Working of Particle Accelerators
    5.3.1 Market Size and Forecast
    5.4 Nuclear Reactors
    5.4.1 Market Size and Forecast
    5.5 Radionuclide Generators
    5.5.1 Market Size and Forecast
    5.6 Production of Radioisotopes Through Radionuclides
    5.6.1 Market Size and Forecast

    Chapter 6 Global Radiotherapy, Radiopharmaceuticals and Nuclear Medicine Market by Technology: Market Size and Forecast, 2018 – 2026
    6.1 Introduction
    6.1.1 Market Size and Forecast
    6.2 External Radiotherapy
    6.2.1 Market Size and Forecast
    6.2.2 Particle Therapy/Proton Beam Therapy
    6.2.2.1 Market Size and Forecast
    6.2.3 Stereotactic Radiosurgery (SRS) and Fractioned Stereotactic Radiation Therapy
    6.2.3.1 Market Size and Forecast
    6.2.4 Image-Guided Radiation Therapy (IGRT)
    6.2.4.1 Market Size and Forecast
    6.2.5 Intensity-Modulated Radiation Therapy (IMRT)
    6.2.5.1 Market Size and Forecast
    6.2.6 Tomotherapy
    6.2.6.1 Market Size and Forecast
    6.2.7 Three-Dimensional Conformal Radiation Therapy (3D-CRT)
    6.2.7.1 Market Size and Forecast
    6.2.8 Volumetric Modulated Arc Therapy (VMAT)
    6.2.8.1 Market Size and Forecast
    6.3 Internal Radiotherapy
    6.3.1 Market Size and Forecast
    6.3.2 Pulse-Dose-Rate (PRD) Brachytherapy
    6.3.2.1 Market Size and Forecast
    6.3.3 Low-Dose-Rate Brachytherapy
    6.3.3.1 Market Size and Forecast
    6.3.4 High-Dose-Rate (HRD) Brachytherapy
    6.3.4.1 Market Size and Forecast
    6.4 Systematic Radiotherapy
    6.4.1 Market Size and Forecast
    6.4.2 Comparison between Alpha and Beta Emitters
    6.4.2.1 Market Size and Forecast

    Chapter 7 Global Radiotherapy, Radiopharmaceuticals and Nuclear Medicine Market by Application: Market Size and Forecast, 2018 – 2026
    7.1 Introduction
    7.1.1 Market Size and Forecast
    7.2 External Beam Radiation Therapy
    7.2.1 Market Size and Forecast
    7.2.2 Treatment Planning for External Beam Radiation
    7.2.2.1 Market Size and Forecast
    7.2.3 Dosing and Treatment with External Beam Radiation
    7.2.3.1 Market Size and Forecast
    7.2.4 Electron-Emitting High-Energy Linear Accelerators
    7.2.4.1 Market Size and Forecast
    7.3 Internal Radiation Therapy
    7.3.1 Market Size and Forecast
    7.4 Systematic Radiation Therapy
    7.4.1 Market Size and Forecast

    Chapter 8 Global Radiotherapy, Radiopharmaceuticals and Nuclear Medicine Market by Geography: Market Size and Forecast, 2018 – 2026
    8.1 Introduction
    8.1.1 Market Size and Forecast
    8.2 North America
    8.2.1 North America Market Size & Forecast, By Country
    8.2.2 North America Market Size & Forecast, By Type
    8.2.3 North America Market Size & Forecast, By Production Type
    8.2.4 North America Market Size & Forecast, By Technology
    8.2.5 North America Market Size & Forecast, By Application
    8.2.6 The U.S.
    8.2.6.1 Market Size and Forecast
    8.2.7 Canada
    8.2.7.1 Market Size and Forecast
    8.2.8 Mexico
    8.2.8.1 Market Size and Forecast
    8.3 Europe
    8.3.1 Europe Market Size and Forecast, By Country
    8.3.2 Europe Market Size and Forecast, By Type
    8.3.3 Europe Market Size and Forecast, By Production Type
    8.3.4 Europe Market Size and Forecast, By Technology
    8.3.5 Europe Market Size and Forecast, By Application
    8.3.6 UK
    8.3.6.1 Market Size and Forecast
    8.3.7 Germany
    8.3.7.1 Market Size and Forecast
    8.3.8 France
    8.3.8.1 Market Size and Forecast
    8.3.9 Italy
    8.3.9.1 Market Size and Forecast
    8.3.10 Spain
    8.3.10.1 Market Size and Forecast
    8.3.11 Rest of Europe
    8.3.11.1 Market Size and Forecast
    8.4 Asia-Pacific
    8.4.1 Asia-Pacific Market Size and Forecast, By Country
    8.4.2 Asia-Pacific Market Size and Forecast, By Type
    8.4.3 Asia-Pacific Market Size and Forecast, By Production Type
    8.4.4 Asia-Pacific Market Size and Forecast, By Technology
    8.4.5 Asia-Pacific Market Size and Forecast, By Application
    8.4.6 India
    8.4.6.1 Market Size and Forecast
    8.4.7 China
    8.4.7.1 Market Size and Forecast
    8.4.8 Australia
    8.4.8.1 Market Size and Forecast
    8.4.9 Japan
    8.4.9.1 Market Size and Forecast
    8.4.10 South Korea
    8.4.10.1 Market Size and Forecast
    8.4.11 Rest of Asia-Pacific
    8.4.11.1 Market Size and Forecast
    8.5 South America
    8.5.1 South America Market Size and Forecast, By Country
    8.5.2 South America Market Size and Forecast, By Type
    8.5.3 South America Market Size and Forecast, By Production Type
    8.5.4 South America Market Size and Forecast, By Technology
    8.5.5 South America Market Size and Forecast, By Application
    8.5.6 Brazil
    8.5.6.1 Market Size and Forecast
    8.5.7 Rest of South America
    8.5.7.1 Market Size and Forecast
    8.6 RoW
    8.6.1 RoW Market Size and Forecast, By Country
    8.6.2 RoW Market Size and Forecast, By Type
    8.6.3 RoW Market Size and Forecast, By Production Type
    8.6.4 RoW Market Size and Forecast, By Technology
    8.6.5 RoW Market Size and Forecast, By Application
    8.6.6 Middle East
    8.6.6.1 Market Size and Forecast
    8.6.7 Africa
    8.6.7.1 Market Size and Forecast

    Chapter 9 Company Profiles
    9.1 Accuray Inc.
    9.2 Actinium Pharmaceuticals Inc.
    9.3 Alliance Medical Group
    9.4 Australian Nuclear Science And Technology Organisation
    9.5 Bayer Pharma Ag
    9.6 Board Of Radiation And Isotope Technology
    9.7 C. R. Bard Inc. (Becton Dickinson)
    9.8 Cardinal Health Inc.
    9.9 Fujifilm Ri Pharma Co. Ltd.
    9.10 GE Healthcare
    9.11 Lantheus Medical Imaging Inc.
    9.12 National Centre For Nuclear Research Polatom
    9.13 National Institute For Radioelements (Ire)
    9.14 NTP Radioisotopes Soc Ltd.
    9.15 Siemens Healthineers
    9.16 Spectrum Pharmaceuticals Inc.
    9.17 Varian Medical Systems
    9.18 Zevacor Molecular

    keyboard_arrow_up
  • Radiotherapy, Radiopharmaceuticals & Nuclear Medicine Market Key Players

    • Accuray Inc.
    • Actinium Pharmaceuticals Inc.
    • Alliance Medical Group
    • Australian Nuclear Science And Technology Organisation
    • Bayer Pharma Ag
    • Board Of Radiation And Isotope Technology
    • R. Bard Inc. (Becton Dickinson)
    • Cardinal Health Inc.
    • Fujifilm Ri Pharma Co. Ltd.
    • GE Healthcare
    • Lantheus Medical Imaging Inc.
    • National Centre For Nuclear Research Polatom
    • National Institute For Radioelements (Ire)
    • NTP Radioisotopes Soc Ltd.
    • Siemens Healthineers
    • Spectrum Pharmaceuticals Inc.
    • Varian Medical Systems
    • Zevacor Molecular
    keyboard_arrow_up


    • Keep your personal detail safe with us. Privacy Policy
      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CLIENTS

SHARE YOUR CART